Optimizatsiya kontrolya nad bronkhial'noy astmoy i khronicheskoy obstruktivnoy bolezn'yu legkikh s pomoshch'yu fiksirovannoy kombinatsii mometazona furoata i formoterola
- Authors: Vizel' A.A1, Vizel' I.Y.1
-
Affiliations:
- Issue: No 15 (2013)
- Pages: 34-39
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/282367
- ID: 282367
Cite item
Open Access
Access granted
Abstract
In Russia, a new fixed combination of mometasone furoate/formoterol with the original dosing aerosol inhaler with a dose counter was registered for the treatment of bronchial asthma. The article presents the key randomized clinical trials on the use of this drug in bronchial asthma and chronic obstructive pulmonary disease, and evaluation of ergonomics and safety of use of the inhaler. The review of these works allows to recommend this fixed combination for the clinical practice as having a sufficient evidence base for the effectiveness and safety in bronchial asthma.
Full Text
References
- Le Moual N, Jacquemin B, Varraso R, Dumas O, Kauffmann F Nadif R. Environment and asthma in adults. Presse Med 2013;42(9):317-33.
- Глобальная стратегия лечения и профилактики бронхиальной астмы (пересмотр 2011 г.). М., 2012. 108 с.
- Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, Fitzgerald M, Leigh R, Watson W, Boulet LP; Canadian Thoracic Society Asthma Clinical Assembly. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012;19(2):127-64.
- Louis R, Schleich F, Barnes PJ. Corticosteroids: still at the frontline in asthma treatment? Clin Chest Med 2012;33(3):531-41.
- Sadigh M, Moskowitz J.P, Шаймуратов Р.И., Zhang H., Визель А.А. Современная терапия бронхиальной астмы // Вестник современной клинической медицины 2012. Т. 5. № 2. С. 48-53.
- Визель А.А., Визель И.Ю. Мометазона фуроат в лечении больных бронхиальной астмой // Эффективная фармакотерапия 2013 (Пульмонология и оториноларингология. № 2). № 21. C. 40-3.
- Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)- 1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-o ne (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther 2006;317(2):762-70.
- Емельянов А.В. Комбинированная терапия бронхиальной астмы: в фокусе внимания мометазона фуроат/формотерол // Российский аллергологический журнал 2013. № 4. С. 60-4.
- Berger WE. Mometasone furoate/formoterol in the treatment of persistent asthma. Expert Rev Respir Med 2011;5(6):739-46.
- Westergaard CG, Porsbjerg C, Backer V. A review of mometasone furoate / formoterol in the treatment of asthma. Expert Opin Pharmacother 2013;14(3):339-46.
- Nathan RA, Nolte N, Pearlman DS. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 mcg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids. Allergy Asthma Proc 2010;31(4):269-79.
- Weinstein SF, Corren J, Murphy K, Nolte H, White M. Study Investigators of P04431 Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids. Allergy Asthma Proc 2010;31(4):280-89.
- Meltzer EO, Kuna P Nolte H, Nayak A, Laforce C. on Behalf of the P04073 Study Investigators. Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function. Eur Respir J 2012;39(2):279-89.
- Nolte H, Pavord I, Backer V, Spector S, Shekar T, Gates D, et al. Dose-dependent antiinflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma. Respir Med 2013;107(5):656-64.
- Wyrwich KW, Ireland AM, Navaratnam P Nolte H, Gates DF An assessment of change in asthma control among adolescents and adults with persistent asthma in Mometasone Furoate/ Formoterol Fumarate clinical trials. J Asthma 2011;48(1):48-56.
- Maspero JF, Nolte H, Cherrez-Ojeda I; P04139 Study Group. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. J Asthma 2010;47(10):1106-15.
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Updated 2013. 76 p.
- Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, et all. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. Int J Chron Obstruct Pulmon Dis 2012;7:43-55.
- Doherty DE, Tashkin DP, Kerwin E, Knorr BA, Shekar T, Banerjee S, et al. Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. Int J Chron Obstruct Pulmon Dis 2012;7:57-71.
- Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T. et al. Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials. Int J Chron Obstruct Pulmon Dis 2012; 7:73-86.
- Weinstein C, Staudinger H, Scott I, Amar NJ, Laforce C. Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med 2011;105(7):979-88.
- Laforce C, Weinstein C, Nathan RA, Weinstein SF, Staudinger H, Meltzer EO. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. J Asthma 2011;48(6): 625-31.
Supplementary files
